PAGET TRIAL: TOPICAL 5% IMIQUIMOD FOR VULVAR PAGET DISEASE, FIRST RESULTS OF CLINICAL EFFICACY

Authors
Category Primary study
JournalINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Year 2019
This article has no abstract
Epistemonikos ID: 36b6f9fee828fd30566576577d255368e510eaa5
First added on: Feb 11, 2025